Mechanistically, we demonstrated that the entry of M1 virus was accelerated via an increase in its binding to the Mxra8 receptor and that the evolved M1 virus overcame the antiviral response by inhibiting the activity of PKR and STAT1 in tumor cells. Here, EIF2AK2 is linked to neoplasm.